News Releases

MaRS Innovation selects Diabetic Wound Healing Technology from The University of Toronto as its second commercialization opportunity
TORONTO (June 30, 2009) – MaRS Innovation and The University of Toronto (U of T) are pleased to announce that they have entered into an agreement to collaboratively commercialize a novel sustained release formulation of nitric oxide (NO) for applications in wound healing, including diabetic ulcers.    “There are 300 million diabetics worldwide, of which some 15 per cent develop troublesome foot ulcers. This wound healing technology is extremely exciting, making it an early commercialization opportunity that MaRS Innovation has identified as being a potential win for some 45 million diabetics globally,” said Dr. Rafi Hofstein, President and ...

Read More

2009

2008

2007

2006

2005

2004

2003

MaRS FACTS

MaRS is part of many networks and consortia, but it did not emanate from any pre-existing partnership. MaRS is a new and autonomous entity.
/magnoliaPublic/dms/mars/banners/rotating/small/bdg_collab/bdg_collab.jpg  2007-08-09 21:39

MaRS BLOG

See more articles

MaRS PICKS

As the Future Catches You
Author: Juan Enriquez Publisher: Crown Business If you think the world has changed dramatically in the last five years, you haven’t seen anything yet. You will never look at the world in the s...

Read More

The Imagination Challenge
Author: Alexander Manu Publisher: Peachpit Press Companies constantly present technological developments-new materials, new mechanisms, and new ways to enhance existing products and services. Yet thes...

Read More



Unlicensed Site Designer. Message: license.invalid.empty